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Abstract
Kidney stone disease is a common health problem in industrialised nations. We developed a SDS-PAGE-
based method to quantify Tamm Horsfall glycoprotein (THP) for screening of kidney stone disease. Uri-
nary proteins were extracted by using ammonium sulphate precipitation at 0.27 g salt/mL urine. The
resulted pellet was dissolved in TSE buffer. Ten microliters of the urinary proteins extract was loaded
and separated on 10% SDS-PAGE under reducing condition. THP migrated as single band in SDS-
PAGE. The assay reproducibility and repeatability were 4.8% CV and 2.6% CV, respectively. A total of
117 healthy subjects and 58 stone patients were tested using this assay, and a distinct cut-off (PG0.05)
at 5.6 μg/mL THP concentration was used to distinguish stone patients from healthy subjects. The sen-
sitivity and specificity of the method were 92.3% and 83.3%, respectively.
Keywords: Kidney stone disease, SDS-PAGE, Tamm Horsfall Protein and diagnostic device.
1. Introduction
Pathogenesis of kidney stone disease involves nucleation, growth,
aggregation, and retention of crystals in the kidney. Biochemical
tests for urinary electrolytes cannot specifically identify the forma-
tion of stone in the kidney. In human, the mechanism against the
formation of kidney stone involves macromolecules, i.e., protein
and glycosaminoglycan that are polyanionic molecules with sub-
stantial amounts of acidic amino acid residues that inhibit crystal
aggregation (1). Tamm Horsfall glycoprotein (THP) is one of
the inhibitors to crystalize aggregation in kidney (2, 3).
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145Tamm Horsfall glycoprotein is the most abundant urinary
protein in healthy individual (4, 5). It is excreted by the thick
ascending limb of the loop of Henle (6). THP is excreted in urine
at a rate of ~50 mg/day and can be influenced by many factors
includingurinevolume,diet,andexercise(7).THPhasamolecular
weight of ~85 kDa although inclines to form macroaggregates of
several million Daltons (8). THP is heavily glycosylated by
N-linked glycans that account for about 30% of its molecular
weight (9). Kidney stone patients excrete THP molecules lacking
terminally linked sialic acid that reduces its inhibitory activity
against stone formation (10). Although reduced urinary THP
excretion in stone patients had been documented (11–13), quanti-
tative analysis of THP by using electroimmunodiffusion shown no
changes in THP excretion levels between stonepatients and healthy
subjects (14, 15). Other studies by using radioimmunoassay and
ELISA shown that THP excretion was inconsistent or reduced in
stone patients (17–19) compared to the healthy subjects (16). In
the studies where analysis of THP was carried out by using SDS-
PAGE, Yokomizoi et al. (11) showed that THP intensity in stone
patients was lower than that of healthy subjects while Pourmand et
al. (20) stated there was no significant difference in THP excretion
between the two cohorts. In our earlier study, we had reported that
THP can be used to differentiate kidney stone patients from healthy
subjects(21).Thecontrodictorydataobtainedbythesevariousstud-
ies may be due to the different proportion of free and aggregated
forms of THP in patients’ urine; furthermore, the two THP forms
have different solubility in salts solutions (7).
The SDS-PAGE-based method for quantification of protein is a
methodofchoiceduetoitssimplicityandreliability,wherebyproteins
are resolved and migrated according to their molecular weights (12).
It has been widely used for analysis of THP in kidney stone disease
(11, 12, 20). In this present study, we aim to develop a non-invasive
SDS-PAGE quantitative method that can be used reliably for screen-
ing of kidney stone disease; THP will be used as the quantifying
marker. THP aggregation will be overcome by the use of a suitable
buffer. Finally, the usability of the developed method as a screening
assayforkidneystonediseasewillbevalidatedandevaluatedbyusing
urine from healthy subjects and stone patients.
2. Methods
2.1. Urine Specimen
Collection Midstreamurinesampleswerecollectedfrom58stoneformers(34
male, 24 female), age range 28–74 years and 117 healthy subjects
146 L. Wai-Hoe et al.(41 male, 76 female) age range 20–86 years. The urine samples
were provided by the Urology Clinic, General Hospital, Pulau
Pinang, and the Lam Wah Ee Hospital, Pulau Pinang, Malaysia.
All stone patients had been confirmed by radiography using plain
abdominal radiography (KUB) and/or intravenous urography
(IVU). Stone patients were afflicted by partial obstruction and non
obstruction kidney stones. Control subjects were asymptomatic of
kidney stone and had no previous history of kidney stone or other re-
nal related diseases, their urine FEME (microscopic) test showed no
redbloodcellspresentandincludedstaffandstudentsintheSchoolof
Pharmaceutical Sciences, USM, and nurses from the nursing institute
of Lam Wah Ee Hospital, Pulau Pinang. Exclusion criteria for this
study are urine samples with urinary creatinine concentration
G2.00 mmol/L and 919.00 mmol/L. Normal range is 2.00–
19.00 mmol/L based on the Cayman Chemical Creatinine Assay.
Urine sample was aliquoted in 1 mL/microcentrifuge tubes and
stored at −20°C before analysis. All the urine samples were analyzed
for THP concentration using ELISA (21).
2.2. Urinary Creatinine
Assay
Creatinine concentration in urine sample was measured by Cayman
ChemicalCreatinineAssay(CaymanChemical Company)withslight
modification. The assay was relied on the Jaffe’ reaction, wherein a
yellow or orange color was formed when the metabolite was treated
with alkaline picrate (22). The color derived from creatinine was then
destroyedatacidicpH.Thedifferenceincolorintensitywasmeasured
at 495 nm before and after acidification is proportional to the creati-
nine concentration (23). A creatinine standard curve was constructed
for determination of creatinine concentration in urine samples.
2.3. Urinary protein
extraction
Urinaryproteinswereextractedfrom1mLurinesamplesbyammo-
nium sulphate salt precipitation (24). The aliquot urine (1 mL) was
thawed to room temperature and added with 0.27 g ammonium
sulphate. After gentle vortex for 2 min, the urine was centrifuged
(10,000 g, 20 min at 20°C) and the pellet was then collected. The
pelletwasdissolvedin80µLTSEbuffer[10mMTris,1mMEDTA,
1% (w/v) SDS, pH 8.8] and 20 µL reducing sample buffer [0.5 M
Tris-HCl at pH 6.8, 20% (v/v) glycerol, 10% (w/v) SDS, 0.5%
(w/v)bromophenol blue and5%β-mercaptoethanol]. Urinaryprotein
was solubilized and reduced by heating at 100°C for 10 min before
loading unto gels.
2.4. Standard THP
Preparation
and Standardization
The Standard THP sample was prepared from the dilution of
commercial THP (Biomedical Technologies; 1 μg/μL) to
0.5 μg/mL. The QC was prepared from pooled normal urine
by ammoniumsulphatesaltprecipitation.TheQCwasusedinmeth-
od validation for precision of the assay. The pellet was dissolved in
TSE buffer, solubilized and reduced in reducing sample buffer with
5% β-mercaptoethanol. The concentration of QC is 0.29 μg/mL
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Ten microliters of the standard THP and the samples were run
concurrentlyinasimilargel.Therelativebandintensityofthestandard
THP to THP from the sample was used to calculate the concentration
of urinary THP in each sample.
2.5. SDS-PAGE
for Urinary THP
Measurement
Urinary proteins were resolved by SDS-PAGE according to a
modified Laemmli method (25). Electrophoresis was performed
in vertical mini-slab gel (Mini-Protean III; BioRad) with a gel
thicknessof0.75mmandgelsize8×7cm. Thegelswerecomposed
of 10% resolving gel and 4% stacking gel and run at constant voltage
of 200 volts for 50 min.
Amountsof10μLofproteinextractswereloadedintoeachwell
of the gel. The same volume of standard THP was added in a sepa-
ratewell alongsidethe samples.After electrophoretic separation,the
gel was stained with Coomassie blue solution (0.01% Coomassie
brilliantblueR250,45%(v/v)methanoland10%(v/v)glacialacetic
acid)for30min atroomtemperature and subsequently destainedin
the destaining solution (50% (v/v) methanol and 2% (v/v) acetic
acid)for1h.ThegelimagewascapturedandanalysedusingVersaDoc
Imaging System (BioRad). THP band intensity relative to standard
THP was used to calculate THP concentration in sample by using
Quantity One 1-D software (BioRad).
2.6. Assay Validation The developed SDS-PAGE was validated for assay precisions, i.e.,
repeatability and reproducibility (26). The repeatability (within
day precision) was calculated by the coefficient of variation
(CV) for QC THP that was run on the same day, whereas repro-
ducibility (between day precision) was calculated from the average
of the within assay precision of QC THP analyzed in three runs at
different day. The cut-off points to differentiate stone formers and
healthy subjects was determined by using trained urine from 58
stone formers and 117 healthy subjects, where the THP concen-
trations of these urine samples were previously measured using the
ELISA method (21). We defined true positive (TP) as the stone
formers’ urine (from patient’ clinical data) with THP concentra-
tion below the cut-off value set, while true negative (TN) was
set as the healthy subjects’ urine with THP concentration above
the cut-off value. In contrast, false positives (FP) were healthy
subjects’ urine with THP concentration below the cut-off value
and vice-versa with false negative (FN) urine. Sensitivity is calcu-
lated as TP/(TP + FN) whereas specificity is TN/(TN + FP) (26);
the results of both calculations are expressed as percentages.
2.7. Data Analysis Data analysis was performed using SPSS v. 15.0. For comparison
betweencohorts,Student’sttestandChi-squaretestwereemployed
and the chosen level of statistical significant was at P=0.05.Allthe
value were presented as mean ± standard error of the mean (SE).
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Sample preparation is an important part of the development of a
quantatitive method. In this study, THP in urine was recovered by
the salt-precipitating technique. Complete recovery of THP in
1 mL urine of healthy subjects was achieved by salting out using
0.27 g of ammonium sulphate (Fig. 1). At this salt to urine ratio,
anintenseTHPbandwasdetectedinthepelletandfaintTHPband,
ifdetectableinthesupernatantfraction,where999%ofurinaryTHP
was recovered (Table 1). Figure 2
Aggregation of THP is the major obstacle for analysis of THP
using SDS-PAGE. As the result of THP aggregation, they form a
large molecular entity that cannot penetrate the resolving gel of
SDS-PAGE(Fig.3).Inthisstudy,thesaltingoutpelletthatcontains
THPwasresolubilisedinTSEbuffer.TSEbufferwasfoundtobethe
bestresolubilizingbufferto preventTHPaggregationand therefore
THP remains in the soluble form. Greater than 90% of THP was
found solubilized in TSE buffer (Table 2). Distilled water is a very
poor medium to solubilized THP (G10%) whereas G20% of THP
solubilized in 0.01 M phosphate buffer saline (PBS) (Fig. 2,
Table 2).
Lane 1 23456
 THP band
Fig. 1. Amount of ammonium sulphate salt [(NH4)2SO4] required for uri-
nary proteins recovery. Lane 1: pellet fraction of 0.27 g (NH4)2SO4; lane
2: supernatant fraction of 0.27 g (NH4)2SO4;l a n e3 :p e l l e tf r a c t i o no f
0.13 g (NH4)2SO4; lane 4: supernatant fraction of 0.13 g (NH4)2SO4; lane
5: pellet fraction of 0.07 g (NH4)2SO4; and lane 6: supernatant fraction of
0.07 g (NH4)2SO4. The gel was silver stained.
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and non-reducing conditions are shown in Fig. 3. In this study,
THP was reduced in 5% β-mercaptoethanol followed by heating
at 100°C for 10 min. THP migrated as 97 kDa and 89 kDa pro-
teins under reduced and non-reduced forms, respectively. Reduc-
ing of THP was found better for analysis by SDS-PAGE as the
reduced form minimizes THP aggregation (Fig. 3).
Table 1
Percentage of urinary THP recovered after precipitated with ammonium sulphate
Amount of (NH4)2SO4
added for precipitation (g)
Intensity (intensity × mm
2)
Percentage of THP recovered
100% - [S/ (P+S) × 100%] Pellet fractions (P)
Supernatant
fractions (S)
0.27 13,883.81 24.77 99.8
0.13 14,043.16 6,619.99 68.0
0.07 12,795.09 4,091.87 75.8
 THP band
 Lane        1  234567
kDa 
250 
150 
100 
75 
50 
37 
25 
20 
15 
Fig. 2. Solubility of salt precipitated urinary proteins in distilled water,
0.01MPBSandTSEbuffer.Lane1:molecularweightmarkers;lane2:pellet
fractionofdistilledwaterbuffer;lane3:supernatantfractionofdistilledwater
buffer; lane 4: pellet fraction of 0.01 M PBS buffer; lane 5: supernatant frac-
tions of0.01 M PBS buffer; lane 6: pellet fractions of TSE buffer; and lane 7:
supernatant fractions of TSE buffer. Salt-precipitated urinary proteins were
dissolved in the indicated buffers. After centrifugation, the recovered
proteins in the pellet fractions and supernatant fractions were separated
by using SDS-PAGE. The gel was stained with Coomassie blue.
150 L. Wai-Hoe et al.Thebestloadingvolumewasat10μL, whereatthisvolumethe
THP band’s intensity for average healthy subjects was below satura-
tion when compared to the THP standard. This is important as the
relativebandintensitywasthebasisofthisquantitativemethod.The
electrophoretic migration of standard THP is identical to that of
THP isolated from urine. Figure 4 show the densitometry analysis
Table 2
Percentage of THP in pellet and supernatant fractions of distilled water, 0.01 M
PBS and TSE buffer
Solubilizing buffer
Intensity (intensity × mm
2) Percentage of THP (%)
Pellet fractions (P)
Supernatant
fractions (S) Pellet fractions (P)
Supernatant
fractions (S)
Distilled water 1,589.47 88.63 94.7 5.3
0.01 M PBS 3,754.06 760.66 83.2 16.8
TSE buffer 373.92 3,523.15 9.6 90.4
  250 kDa 
     150 kDa 
 100 kDa 
          75 
   50 kDa 
   37 
    25 
       20 kDa 
     15 kDa
              Reducing condition                         Non-reducing condition 
Lane           1         2        3       4    5          6       7       8       9
    THP band
   THP band 
Fig. 3. Urinary proteins profileunder reducingand non-reducingconditions.
Lane1–4:urinaryproteinsunderreducingcondition;lane5:molecularweight
markers; and lane 6–9: urinary proteins under non-reducing condition. The
gel was Coomassie blue stained. The diagram shows the consistent urinary
proteins profiles under reducing and non-reducing condition. The figure
shows the SDS-PAGE profile of urinary proteins under reducing and non-
reducing conditions.
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dardTHPandTHPisolatedfromurine.ThedevelopedSDS-PAGE
method was validated for assay precisions, i.e., reproducibility and
repeatability. The assay precisions were 4.8% CV for reproducibility
and 2.6% CV for repeatability (Table 3). Figure 6 shows a standard
curve for a serial dilution of THP standard, where the densitometry
reading of the serial diluted THP bands rise in proportional to the
increase in THP concentration. Figure 7 shows an example of
Fig. 4. Densitometry chromatogram of Standard THP. The intensity of
standard THP was 3,253.112.
Fig. 5. A single THP band was found at 95 kDa in the immunoblot. Lane
1: standard THP; lanes 3 and 4: THP isolated from 2 different healthy
subjects; and lane 5: THP isolated from a stone former.
152 L. Wai-Hoe et al.SDS-PAGE urinary protein profile in healthy subjects and stone
patients. An intense THP band was detected in healthy subject but
a very faint band, if detectable, was observed in stone patients.
By usingthe developedSDS-PAGE method, urine samples from
117 healthy subjects and 58 stone patients were analyzed. Figure 8
shows a strong positive correlation (r=0.781, P=0.002) between
THP concentrations and THP excretions (THP/Creatinine ratio)
asmeasuredbySDS-PAGE.The95%confidentintervalofTHPcon-
centration in the healthy subjects was 29.34–45.98 μg/mL and
51.86–72.69 μg/mL for male and female, respectively. The THP
concentrationandTHPexcretionforfemalehealthysubjectswassig-
nificantly higher (THP concentration=62.28±5.23 μg/mL,
P=0.0002;THPexcretion=8.89±0.63mg/mmol,P=0.0004)than
thatoftheircounterpart(Table4).Ontheotherhand,stonepatients
Table 3
Reproducibility and repeatability of SDS-PAGE
Reproducibility (between day assay)
OD reading (n=2) Mean THP concentration of QC (μg/mL)
Day 1 0.29
Day 2 0.27
Day 3 0.27
Day 4 0.27
Day 5 0.26
Average 0.27
Standard deviation (SD) 0.01
Coefficient of variation (CV) 4.8%
Repeatability (within day assay)
OD reading (n=2) Mean THP concentration of QC (μg/mL)
1 0.30
2 0.28
3 0.29
Average 0.29
Standard deviation (SD) 0.01
Coefficient of variation (CV) 2.6%
The measurement of QC was carried out over 5 days.
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Lane             1               2              3               4             5
kDa 
200
116.3
97.4
66.2 
45.0
31.0
21.5
14.4
 THP band
Fig. 7. SDS-PAGE urinary protein profile of standard THP, healthy sub-
ject, stone patients. Lane 1: protein markers; lane 2: healthy subject; lane
3: standard THP; lane 4 and 5: stone patients.
154 L. Wai-Hoe et al.excretedsignificantlylowerTHPconcentration(1.71±0.19μg/mL,
P=0.0001) and THP excretion (0.29±0.04 mg/mmol, P=0.0003)
than those of the healthy subjects (Table 4) although they did not
showanydifferencesinTHPconcentrationinregardstopatientgen-
der.ThedistributionofindividualTHPconcentrationof117healthy
subjects and 58 stone formers is shown in Fig. 9. The best fit line to
distinguish healthy subjects from stone patients was found at
5.60 μg/mL THP concentration (PG0.05).
A blind test was conducted on 68 subjects comprising of 26
stone formers and 42 healthy subjects. By using 5.60 μg/mL of
THP as the cut-off value to differentiate healthy subjects from
stone formers, we found that 2 out of 26 stone formers fall under
the false negative category while 7 out of 42 healthy subjects fall
under the false positive category. Thus, the sensitivity of the assay
was 92.3% while its specificity was 83.3%.
4. Discussion The insoluble substances presence in urine will interfere with elec-
trophoretic migration of proteins in SDS-PAGE and thus hinder
accurate analysis of urinary protein pattern (27). Isolation of
THP concentration (ug/mL) measured by SDS-PAGE
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Fig. 8. The correlation between THP concentration and THP excretion
measured by SDS-PAGE. The □ symbols represent the THP level of an
individual urine sample with its corresponding THP concentration and
THP excretion. The THP concentration was correlated positively to
THP excretion (r=0.781, P=0.002). The level of significance according
to Pearson correlation of coefficient was set to alpha=0.01.
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itation as most of the proteins can be precipitated in the presence of
high salt concentration (27) leaving behind potential contaminants
(e.g., nucleic acids) that cannot be precipitated in urine solution
(27, 28). Trace quantity of THP can be effectively recovered using
this technique (29). Ammonium sulphate precipitation is a rapid
and cost effective technique for urinary proteins isolation when a large
number of urine samples are involved.
Proteins separation in SDS-PAGE is frequently hampered by
their self-aggregation. It was documented that THP exists in aggre-
gated state in urine (30). THP aggregation was influenced by pH,
ionic strength, and certain types of cation particularly bivalent
cations in its solubilising matrix (31). TSE is the best buffer to pre-
serve urinary THP in soluble form or even cause dissociation of
THPaggregates.TheTSEconsistsof10mMTris,whichisalowsalt
concentration buffer used to prevent THP aggregation; 1% SDS,
which is an effective solubilisation agent for THP by disrupting
the hydrophobic interactions between THP molecules (28, 32);
1 mM EDTA, which is a protease inhibitor to reduce proteolysis
and prevent divalent metal ions chelation and ; pH 8.8, in which
THP was preserved in soluble form (7, 33). The composition of
TSE buffer has synergistically effect on THP disaggregation and
maintaining it in a soluble form.
Table 4
The average age, Creatinine concentration, THP concentration and THP/Creat
ratio in healthy subjects, stone patients
No. of
sample
Age
(age range)
(years)
Creatinine
concentration
(mmol/L)
THP
concentration
(µg/mL)
THP/Creat
ratio
(mg/mmol)
Healthy subjects 117 32 (18–86) 8.14±0.40 53.65±3.84 7.62±0.50
Male 41 52 (19–86) 9.15±0.74 37.66±4.12 5.25±0.68
Female 76 21 (18–60) 7.59±0.46 62.28±5.23
a 8.89±0.63
b
Stone patients 58 52 (28–74) 7.94±0.54 1.71±0.19
c 0.29±0.04
d
Male 34 52 (36–74) 7.50±0.67 2.03±0.26 0.35±0.05
Female 24 52 (28–68) 8.57±0.88 1.25±0.24 0.21±0.06
All the value expressed as mean ± SE.
aSignificant compared with male healthy subjects, P=0.0004
bSignificant compared with male healthy subjects, P=0.0002
cSignificant compared with healthy subjects, P=0.0001
dSignificant compared with healthy subjects, P=0.0003
156 L. Wai-Hoe et al.Under non-reducing condition, the THP molecules appeared
in partially aggregated and partially soluble forms. In SDS-PAGE,
the non-reduced THP migrated at a lower molecular weight than
the reduced THP. The decrease in molecular weight observed is
due to a high degree of polypeptide constraint imposed by a large
number of intrachain disulfide bridges formed in the non-reduced
THP molecule (34). Reducing of urinary proteins in 1% SDS and
5% β-mercaptoethanol yielded consistent and reproducible pro-
tein migration pattern in SDS-PAGE, which serve as one of the
criteria for total urinary THP quantification in the present study.
Amount of protein sample loaded onto SDS-PAGE is one of
the critical criteria to producing good protein resolution. Since
the electrophoretic pattern of protein separated by SDS-PAGE
will be affected by the amount of protein loaded, it is important
n o tt oo v e r l o a dt h eg e lt oa v o i dad i s t o r t e db a n dp a t t e r n .I ns l a bg e l ,
overloading of protein in one lane can distort the band pattern in
the adjacent lane. On the other hand, an underloaded gel will reduce
thedetectionoftraceproteinsinthemixture(35).Hence,thequantity
5.60
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Fig. 9. Establishing of cut-off value for SDS-PAGE. The о symbols repre-
sent an individual urine sample at its corresponding THP concentration.
The horizontal line was the selected cut-off for SDS-PAGE. The cut-off of
THP concentration was set at 5.60 μg/mL. There were 117 healthy sub-
jects and 58 stone patients assayed by this method.
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and intensity. By using the stated protein isolation procedure, we
found that the optimal sample volume for THP analysis is 10 μL,
t h eg e l sw e r es t a i n e dw i t hC o o m a s s i eb l u ea n dt h ec o l o ri n t e n s i t yf o r
THPbandsissetbelowthesaturationpixeloftheimager.Byusingthis
approach,wecandetectthedifferencesinTHPproteinconcentrations
within the sensitivity of Coomassie blue stain (36). The intensity of the
THP band relied on the interaction of the protein with aminotriaryl-
methane dye of Coomassie Brilliant blue; as dye component may vary
from batch to batch, standard THP was run concurrently with the
samples in each analysis. The robustness of the assay is proven by the
good reproducibility and repeatability of the assay, which were 4.8%
and 2.6% CV, respectively.
The method developed was tested on a group of healthy sub-
jects and kidney stone patients. In both the cohorts, urinary THP
appeared as a single band and migrated at identical molecular
weight on SDS-PAGE. The role of sialic acid content of THP
molecule in stone formation has been addressed previously
(2, 10, 37). Glycosylation of THP in healthy subjects was said
to have a protective function on tubular epithelium whilst stone
patients excreted defective urinary THP containing less sialic acid
and thus diminishing its inhibitory effect on crystal aggregation
(10, 38, 39). Since sialic acid content on a glycoprotein will inter-
fere with the migration of the glycoprotein in SDS-PAGE, one
can predict that the migration of THP isolated from the healthy
subjects will be different from those of the stone patients. In this
study, we observed a homogeneous migration of urinary THP on
SDS-PAGE in both the cohorts, which is an added advantage for
the quantification of THP. Hess et al. (37), however, suggested
that not only defective THP but a decreased THP excretion
may promote the formation of kidney stones.
Urinarycreatinineconcentrationwasusedasthecorrectionfactor
fortheeffect ofurinehydrationonTHPconcentration(40).Weused
urinary creatinine concentration to estimate THP excretion, which
was expressed as THP/Creat ratio. In this study, we found that uri-
nary THP excretion in stone patients was significant lower than that
ofthehealthysubjects.OurfindingisinagreementwithYokomizoiet
al. (11) although contradictory to Pourmand et al. (20) who reported
that no significant difference was detected between the two cohorts.
Nevertheless, other studies using radioimmunoassay or ELISA have
shownthatexcretionofTHPinstonepatientswaslowerascompared
to that of healthy subjects (17–19).
We have shown that the currently developed SDS-PAGE
method can be used as a reliable quantitative method for determi-
nation of urinary THP concentration. Upon testing with 117
healthy subjects and 58 stone former, 5.6 μg/mL THP concen-
tration (PG0.05) was set as the cut-off point to distinguish stone
patients from the healthy subjects. It was then blind-tested on a
158 L. Wai-Hoe et al.group of 68 subjects, from which the sensitivity and specificity of
the development method was determined to be 92.3% and 83.3%,
respectively. Nevertheless, the specificity of the method may be
increased if it is used in the context for screening of kidney stone
disease when the clinical symptoms for the disease are shown in
the patients. Furthermore, this method is simple to perform, cost
effective and with high reproducibility. This non-invasive SDS-
PAGE-based quantification method may be the answer to diagno-
sis of kidney stone disease.
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